Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract

BACKGROUND: Biliary tract carcinoma (BTC) is a fatal malignancy which aggressiveness contrasts sharply with its relatively mild and late clinical presentation. Novel molecular markers for early diagnosis and precise treatment are urgently needed. The purpose of this study was to evaluate the diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Branchi, V., Schaefer, P., Semaan, A., Kania, A., Lingohr, P., Kalff, J. C., Schäfer, N., Kristiansen, G., Dietrich, D., Matthaei, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153824/
https://www.ncbi.nlm.nih.gov/pubmed/27999621
http://dx.doi.org/10.1186/s13148-016-0299-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153824/
https://www.ncbi.nlm.nih.gov/pubmed/27999621
http://dx.doi.org/10.1186/s13148-016-0299-x

Ejemplares similares